By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
BioSapien is a preclinical oncology biotechnology company developing innovative cancer treatment solutions with its flagship product, MediChip. The company primarily focuses on creating a patented, slow-release drug delivery platform designed to treat cancers locally while minimizing systemic side effects associated with conventional chemotherapy
